HANISH ARNOLD C
Insider CIK 1233253 · OMER Director · DCOY Director · LLY Chief Accounting Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DCOY Decoy Therapeutics Inc. | A Award | 2026-08-31 | 2026-09-02 | 3,000 | — | $0 | 3,418 | SEC↗ |
| DCOY Decoy Therapeutics Inc. | A Award | 2026-08-31 | 2026-09-02 | 3,000 | — | $0 | 3,418 | SEC↗ |
| OMER OMEROS CORP | M Exercise deriv | 2026-08-27 | 2026-08-28 | 7,500 | — | $0 | 0 | SEC↗ |
| OMER OMEROS CORP | M Exercise deriv | 2026-08-27 | 2026-08-28 | 2,500 | — | $0 | 0 | SEC↗ |
| OMER OMEROS CORP | M Exercise | 2026-08-27 | 2026-08-28 | 2,500 | $15.81 | $39.5K | 2,500 | SEC↗ |
| OMER OMEROS CORP | S Sale | 2026-08-27 | 2026-08-28 | 5,000 | $18.88 | $94.4K | 5,000 | SEC↗ |
| OMER OMEROS CORP | M Exercise | 2026-08-27 | 2026-08-28 | 7,500 | $14.66 | $110.0K | 10,000 | SEC↗ |
| OMER OMEROS CORP | S Sale | 2026-08-27 | 2026-08-28 | 5,000 | $19.02 | $95.1K | 0 | SEC↗ |
| OMER OMEROS CORP | M Exercise deriv | 2026-08-27 | 2026-08-28 | 7,500 | — | $0 | 0 | SEC↗ |
| OMER OMEROS CORP | M Exercise deriv | 2026-08-27 | 2026-08-28 | 2,500 | — | $0 | 0 | SEC↗ |
| OMER OMEROS CORP | S Sale | 2026-08-27 | 2026-08-28 | 5,000 | $19.02 | $95.1K | 0 | SEC↗ |
| OMER OMEROS CORP | S Sale | 2026-08-27 | 2026-08-28 | 5,000 | $18.88 | $94.4K | 5,000 | SEC↗ |
| OMER OMEROS CORP | M Exercise | 2026-08-27 | 2026-08-28 | 7,500 | $14.66 | $110.0K | 10,000 | SEC↗ |
| OMER OMEROS CORP | M Exercise | 2026-08-27 | 2026-08-28 | 2,500 | $15.81 | $39.5K | 2,500 | SEC↗ |
| OMER OMEROS CORP | M Exercise deriv | 2026-08-26 | 2026-08-28 | 5,000 | — | $0 | 2,500 | SEC↗ |
| OMER OMEROS CORP | M Exercise | 2026-08-26 | 2026-08-28 | 5,000 | $15.81 | $79.0K | 5,000 | SEC↗ |
| OMER OMEROS CORP | S Sale | 2026-08-26 | 2026-08-28 | 5,000 | $18.53 | $92.7K | 0 | SEC↗ |
| OMER OMEROS CORP | M Exercise deriv | 2026-08-26 | 2026-08-28 | 5,000 | — | $0 | 2,500 | SEC↗ |
| OMER OMEROS CORP | S Sale | 2026-08-26 | 2026-08-28 | 5,000 | $18.53 | $92.6K | 0 | SEC↗ |
| OMER OMEROS CORP | M Exercise | 2026-08-26 | 2026-08-28 | 5,000 | $15.81 | $79.0K | 5,000 | SEC↗ |
| OMER OMEROS CORP | A Award deriv | 2026-06-18 | 2026-06-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | S Sale | 2025-12-30 | 2026-01-02 | 12 | $0.64 | $8 | 0 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | S Sale | 2025-12-30 | 2026-01-02 | 15 | $0.64 | $10 | 5,000 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | P Buy | 2025-11-20 | 2025-11-24 | 5,000 | $0.75 | $3.8K | 5,015 | SEC↗ |
| OMER OMEROS CORP | A Award deriv | 2025-06-27 | 2025-07-01 | 15,000 | — | $0 | 15,000 | SEC↗ |
| OMER OMEROS CORP | A Award deriv | 2024-06-06 | 2024-06-07 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | A Award deriv | 2024-02-20 | 2024-02-22 | 20,500 | — | $0 | 20,500 | SEC↗ |
| OMER OMEROS CORP | A Award deriv | 2023-06-23 | 2023-06-27 | 15,000 | — | $0 | 15,000 | SEC↗ |
| OMER OMEROS CORP | M Exercise deriv | 2023-05-22 | 2023-05-23 | 5,000 | — | $0 | 0 | SEC↗ |
| OMER OMEROS CORP | S Sale | 2023-05-22 | 2023-05-23 | 5,000 | $6.46 | $32.3K | 0 | SEC↗ |
| OMER OMEROS CORP | M Exercise | 2023-05-22 | 2023-05-23 | 5,000 | $5.30 | $26.5K | 5,000 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | A Award | 2023-01-03 | 2023-01-05 | 1,440 | — | $0 | 1,440 | SEC↗ |
| OMER OMEROS CORP | A Award deriv | 2022-09-21 | 2022-09-23 | 7,500 | — | $0 | 7,500 | SEC↗ |
| OMER OMEROS CORP | A Award deriv | 2022-06-17 | 2022-06-22 | 7,500 | — | $0 | 7,500 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | P Buy | 2022-06-03 | 2022-06-06 | 28,000 | $0.18 | $5.0K | 46,350 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | A Award deriv | 2022-01-20 | 2022-01-21 | 30,000 | — | $0 | 30,000 | SEC↗ |
| OMER OMEROS CORP | M Exercise deriv | 2021-09-08 | 2021-09-09 | 10,000 | — | $0 | 5,000 | SEC↗ |
| OMER OMEROS CORP | M Exercise | 2021-09-08 | 2021-09-09 | 10,000 | $9.44 | $94.4K | 10,000 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | P Buy | 2021-08-10 | 2021-08-11 | 7,000 | $0.88 | $6.2K | 18,350 | SEC↗ |
| OMER OMEROS CORP | A Award deriv | 2021-06-11 | 2022-02-14 | 7,500 | — | $0 | 7,500 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | A Award deriv | 2020-12-02 | 2020-12-04 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | P Buy | 2020-08-21 | 2022-06-06 | 4,000 | $0.98 | $3.9K | 11,350 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | P Buy | 2020-08-21 | 2020-08-24 | 4,000 | $0.98 | $3.9K | 11,350 | SEC↗ |
| OMER OMEROS CORP | A Award deriv | 2020-06-05 | 2020-06-09 | 7,500 | — | $0 | 7,500 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | A Award deriv | 2020-03-23 | 2020-03-25 | 6,000 | — | $0 | 6,000 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | P Buy | 2020-02-11 | 2022-06-06 | 4,350 | $1.15 | $5.0K | 7,350 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | P Buy deriv | 2020-02-11 | 2020-02-13 | 4,350 | $0.01 | $44 | 4,350 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | P Buy | 2020-02-11 | 2020-02-12 | 4,350 | $1.15 | $5.0K | 7,350 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | P Buy | 2019-11-25 | 2022-06-06 | 3,000 | $3.59 | $10.8K | 3,000 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | P Buy | 2019-11-25 | 2020-02-12 | 3,000 | $3.59 | $10.8K | 3,000 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | P Buy | 2019-11-25 | 2019-11-26 | 3,000 | $3.59 | $10.8K | 6,000 | SEC↗ |
| SLRX Salarius Pharmaceuticals, | A Award deriv | 2019-09-10 | 2019-09-12 | 3,000 | — | $0 | 3,000 | SEC↗ |
| OMER OMEROS CORP | A Award deriv | 2019-06-07 | 2019-06-11 | 7,500 | — | $0 | 7,500 | SEC↗ |
| OMER OMEROS CORP | A Award deriv | 2018-06-15 | 2018-06-18 | 7,500 | — | $0 | 7,500 | SEC↗ |
| OMER OMEROS CORP | A Award deriv | 2017-06-16 | 2017-06-16 | 10,000 | — | $0 | 10,000 | SEC↗ |
| OMER OMEROS CORP | A Award deriv | 2016-06-09 | 2016-06-10 | 7,500 | — | $0 | 7,500 | SEC↗ |
| OMER OMEROS CORP | A Award deriv | 2015-05-22 | 2015-05-27 | 5,000 | — | $0 | 5,000 | SEC↗ |
| OMER OMEROS CORP | A Award deriv | 2014-05-23 | 2014-05-28 | 5,000 | — | $0 | 5,000 | SEC↗ |
| OMER OMEROS CORP | A Award deriv | 2013-05-24 | 2013-05-28 | 5,000 | — | $0 | 5,000 | SEC↗ |
| OMER OMEROS CORP | P Buy | 2013-01-03 | 2013-01-03 | 2,000 | $5.58 | $11.2K | 2,400 | SEC↗ |
| OMER OMEROS CORP | A Award deriv | 2012-09-26 | 2012-09-28 | 15,000 | — | $0 | 15,000 | SEC↗ |
| LLY LILLY ELI & CO | G Gift | 2012-08-29 | 2012-10-30 | 136 | — | $0 | 17,611 | SEC↗ |
| LLY LILLY ELI & CO | S Sale | 2012-05-18 | 2012-05-21 | 1,295 | $40.49 | $52.4K | 17,747 | SEC↗ |
| LLY LILLY ELI & CO | G Gift | 2012-05-02 | 2012-05-21 | 238 | — | $0 | 19,042 | SEC↗ |
| LLY LILLY ELI & CO | A Award | 2012-01-26 | 2012-01-30 | 2,210 | $39.44 | $87.2K | 19,255 | SEC↗ |
| LLY LILLY ELI & CO | A Award | 2012-01-26 | 2012-02-02 | 2,235 | $39.44 | $88.1K | 19,280 | SEC↗ |